World's most versatile flashcards

or...
Reset Password Sign Up

drug sheet

        Help  

Question
Answer
Adenosine other names   Adenocard  
Class:   Antiarrhythmic  
Pharmacology and Actions   A. Endogenous nucleoside – present in all cell bodies  
Pharmacology and Actions   B. Slows conduction time through the A-V node  
Pharmacology and Actions   C. Can interrupt reentry pathways through the A-V node  
Pharmacology and Actions   D. Removed rapidly from circulation by erythrocytes and vascular endothelial cells. Half life is less than 10 seconds  
Indications   A. PSVT, SVT  
Indications   B. PSVT associated with WPW  
Contraindications   A. Does not convert Atrial Flutter, Atrial Fibrillation, or Ventricular Tachycardia  
Contraindications   B. Second or third degree A-V block  
Contraindications   C. Sick sinus syndrome  
Precautions and Side Effects   A. Antagonized by caffeine and theophylline due to prevention of adenosine binding at receptor sites. May need larger dose.  
Precautions and Side Effects   B. Potentiated by dipyridamole (persantine). May need smaller dose.  
Precautions and Side Effects   C. May produce a short lasting first, second, or third degree heart block  
Precautions and Side Effects   D. In extreme cases it may cause prolonged asystole.  
Precautions and Side Effects   E. May produce arrhythmias at the time of conversion which should only last a short while including PVC’s, PAC’s, sinus brady, sinus tach, skipped beats and varying degrees of A-V blocks  
Precautions and Side Effects   F. Tegretol may result in development of high-degree blocks. May need smaller dose.  
Precautions and Side Effects   G. May cause dizziness, flushing, HA, numbness in arms, dyspnea, chest pain, palpitations, nausea, chest pressure, bronchospasm, feeling of impending doom and heaviness in arms and neck  
Dosages and supplied   1st dose 6mg push, 2nd & 3rd dose 12mg. max 30mg..... supplied 6mg/2ml or 12mg/4ml  


   


 

 

 

 

 

 
Follow us on Twitter
Be a StudyStack fan on Facebook
www.eapps.com




Copyright ©2001-2009 John Weidner All rights reserved.
About -  Terms of Service -  Privacy Statement